secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elanco Animal Health Inc (ELAN)
CIK:        0001739104
Form:       8-K
Filed at:   2026-05-27T21:00:57+00:00
Accession:  0001104659-26-067002
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Elanco shareholders elect all director nominees, ratify EY, approve say-on-pay at annual meeting
--------------------------------------------------------------------------------

- All five director nominees elected; highest support for Lawrence Kurzius (443M for).
- Ratification of Ernst & Young as auditor for 2026: 480M for, 2.6M against.
- Advisory vote on executive compensation approved: 383.5M for, 84.2M against.
- Broker non-votes totaled 15.4M for director and say-on-pay proposals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1739104/000110465926067002/0001104659-26-067002-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1739104/000110465926067002/tm2615566d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-067002

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer